Sunrest Lifescience Limited IPO Detail
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
Company Promoters
Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar.IPO Details
| IPO Opening Date | Nov 07, 2023 |
| IPO Closing Date | Nov 09, 2023 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹84 per equity share |
| Market Lot | 1600 Shares |
| Min Order Quantity | 1600 Shares |
| Listing At | NSE SME |
| Issue Size | ₹10.85 Cr |
| Fresh Issue | ₹10.85 Cr |
| Offer for Sale | - |
| Retail Portion | 50% |
IPO Subscription (Bidding Detail)
| AS On | QIB | SHNI | BHNI | NII | RII | TOTAL |
|---|---|---|---|---|---|---|
| Day 1 | - | - | 0.62x | 5.79x | 3.21x | |
| Day 2 | - | - | 2.67x | 19.78x | 11.23x | |
| Day 3 | - | - | 29.17x | 65.74x | 48.54x |
IPO Tentative Timetable
The Sunrest Lifescience Limited IPO open date is Nov 07, 2023, and the close date is Nov 09, 2023. The issue may list on Nov 20, 2023.
| IPO Open Date | Nov 07, 2023 |
| IPO Close Date | Nov 09, 2023 |
| Basis of Allotment Date | Nov 15, 2023 |
| Initiation of Refunds | Nov 16, 2023 |
| Credit of Shares to Demat Account | Nov 17, 2023 |
| IPO Listing Date | Nov 20, 2023 |
IPO Lot Size
The Sunrest Lifescience Limited IPO market lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹134400).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 1600 | ₹134400 |
| Maximum | 1 | 1600 | ₹134400 |
IPO Promoter Holding
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 69.91% |
Company Financials:
For the year/period ended (₹ in Lakhs)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 948.15 | 1694.91 | 16.55 |
| 31-Mar-22 | 1301.97 | 2690.99 | 77.71 |
| 31-Mar-23 | 1671.37 | 2467.05 | 204.31 |
Objects of the Issue:
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
1. Meeting Working Capital Requirements
2. General Corporate Purpose
3. Meeting Public Issue Expenses
Sunrest Lifescience Limited IPO Registrar:
Skyline Financial Services Private Ltd
Sunrest Lifescience Limited IPO Lead Manager(s):
Mark Corporate Advisors Private Limited
Company Contact Information:
Sunrest Lifescience Limited
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar, Bus Stand Vastral Road,
Ahmedabad-382415
